Abstract:BACKGROUND: Liver transplantation is a life-saving therapy for end-stage liver disease patients, but acute cellular rejection (ACR) and graft complications remain significant postoperative challenges. Early and accurate diagnosis is crucial for timely intervention and improved patient outcomes, but their diagnosis rely currently on invasive biopsy sampling, thus prompting the search for non-invasive Biomarkers. MicroRNA (miRNA) have emerged as promising biomarkers in various pathological conditions, and their potential utility in diagnosing acute cellular rejection after liver transplantation has gained significant interest.METHODS: This systematic review of PubMed, Web of Science, and the ClinicalTrials.gov registry analyzes studies exploring miRNA as biomarkers for ACR and graft dysfunction in liver transplantation (PROSPERO ID CRD42023465278). The Cochrane Collaboration tool for assessing risk of bias was employed. Population data, identified miRNA and their dynamic regulation, as well as event prediction were compared. Data extraction and quality assessment were performed independently by two reviewers.RESULTS: Thirteen studies were included in this systematic review. Various investigated miRNAs were upregulated in association with acute cellular rejection, like miR-122, miR-155, miR-181, miR-483-3p, and miR-885-5p, demonstrating great biomarker potential. Additionally, several studies conducted target gene analysis, revealing insights into cellular mechanisms linked to ACR. Moreover, various miRNA were also capable of predicting different organ complications following transplantation, expanding their versatility. Remaining challenges include the standardization of miRNA profiling, the need for functional validation, and the necessity for long-term studies.CONCLUSION: The results highlight the potential of miRNA as specific, non-invasive biomarkers for ACR and graft dysfunction following liver transplantation. However, further research is needed to validate these findings and establish standardized diagnostic panels to incorporate them into clinical practice and explore miRNA-based therapies in the future.

miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures

Identification of Candidate Biomarkers in Peripheral Blood for Cardiac Allograft Rejection Based on Bioinformatics Analysis

miRNA as potential biomarkers after liver transplantation: A systematic review

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease.

MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Plasma Microrna, A Potential Biomarker for Acute Rejection after Liver Transplantation

Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up

Dysfunctional Cori and Krebs cycle and inhibition of lactate transporters constitute a mechanism of primary nonfunction of fatty liver allografts

Plasma Mirna-122-5p and Mirna-151A-3p Identified As Potential Biomarkers for Liver Injury among CHB Patients with PNALT

Circulating MicroRNAs As Potential Biomarkers for Alcoholic Steatohepatitis.

Proteomic Signature of Acute Liver Failure: from Discovery and Verification in a Pig Model to Confirmation in Humans.

Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction

Downregulation of Cyclic Microrna-199A-3p May Be Early Warning Index of Acute Rejection after Liver Transplantation

MicroRNA-146b-5p Identified in Porcine Liver Donation Model is Associated with Early Allograft Dysfunction in Human Liver Transplantation.

Serum microRNA-181a Expression Level in Patients with Acute Liver Failure and Its Correlation with Prognosis

Identifying 4 Novel Lncrnas As Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft.

A proteomic analysis of transplanted liver in a rat model of chronic rejection.

[Differential Expressions of Micrornas and Their Predicted Targets in Liver Transplant Recipients with Long-Term Stable Survival].

Mitochondrial miR-23b-5p is a new biomarker of warm ischaemic injury in donor livers and a candidate for graft evaluation: experimental studies